STOCK TITAN

Arteris, Inc. (AIP) SEC Filings, Aug-Sep 2025

AIP NASDAQ

Arteris, Inc. filings document a semiconductor technology business built around System IP for SoC and chiplet design. Its 8-K reports cover quarterly and annual operating results, financial-condition updates, guidance exhibits, customer shipment milestones, royalty trends and product portfolio disclosures for network-on-chip interconnect IP, SoC integration automation software and hardware security assurance.

The company’s proxy materials cover board elections, executive compensation, equity incentive arrangements and stockholder voting matters. They also describe governance and business context for Arteris’ markets, including automotive, artificial intelligence and machine learning, 5G communications, data centers, edge computing, enterprise and consumer electronics.

Rhea-AI Summary

Arteris, Inc. (AIP) reporting person Paul L. Alpern, VP and General Counsel, disclosed a routine sale of common stock on 09/02/2025. The Form 4 shows 258 shares sold at $8.9417 per share under transaction code S(1), with the filing explaining the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units. Following the sale, Mr. Alpern beneficially owns 76,289 shares directly. The form is signed by Paul Alpern on 09/03/2025 and indicates a single reporting person filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Arteris, Inc. (AIP) Form 4 filing: 10% owner Bayview Legacy, LLC, managed by CEO K. Charles Janac, reported the sale of 50,000 common shares on 08/05/2025. The trade, executed under a Rule 10b5-1 plan adopted 03/05/2025, was coded “S” (open-market sale). Weighted-average price: $13.1199, with individual transactions between $12.35 and $14.20.

Following the sale, Bayview Legacy’s indirect beneficial ownership stands at 9,839,071 shares. No derivative transactions were reported. Janac has filed a separate Form 4 reflecting the same activity due to his control of the LLC.

The disposition represents roughly 0.5% of Bayview Legacy’s post-transaction holdings, leaving the insider with a substantial stake and signaling limited portfolio rebalancing rather than a material exit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.96%
Tags
quarterly report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.96%
Tags
other
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.96%
Tags
other

FAQ

How many Arteris (AIP) SEC filings are available on StockTitan?

StockTitan tracks 243 SEC filings for Arteris (AIP), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Arteris (AIP)?

The most recent SEC filing for Arteris (AIP) was filed on September 3, 2025.